SCHEMBL8441968

SCHEMBL8441968

CCN[C@@H](C)Cc1ccc(O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.66
SLC6A4 P31645 3/20 0.62
ADRB2 P07550 7/20 0.57
CYP3A4 P08684 3/20 0.57
MAPK1 P28482 3/20 0.57
NPSR1 Q6W5P4 2/20 0.57
ADRB1 P08588 2/20 0.57
ADRB3 P13945 2/20 0.57
SLC6A2 P23975 2/20 0.57
CYP2D6 P10635 1/20 0.57
TSHR P16473 1/20 0.57
HIF1A Q16665 1/20 0.57
HSD17B10 Q99714 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
PTGS1 P23219 1/20 0.57
HTR2A P28223 1/20 0.57
MC4R P32245 1/20 0.57
ADRA1A P35348 1/20 0.57
OPRM1 P35372 1/20 0.57
MC3R P41968 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14521880 1.00 SIGMAR1 (0.66) SIGMAR1SLC6A4ADRB2CYP3A4MAPK1
SCHEMBL26969037 1.00 SIGMAR1 (0.66) SIGMAR1SLC6A4ADRB2CYP3A4MAPK1
SCHEMBL10662965 0.85 SIGMAR1 (0.68) SIGMAR1SLC6A4ADRB2CYP3A4MAPK1
SCHEMBL19012043 0.82 SIGMAR1 (0.68) SIGMAR1SLC6A4CYP3A4CYP2D6TSHR
SCHEMBL5269077 0.81 SIGMAR1 (0.61) SIGMAR1SLC6A4ADRB2CYP3A4MAPK1
SCHEMBL18181945 0.81 OPRK1 (0.66) SIGMAR1SLC6A4ADRB2CYP3A4MAPK1
SCHEMBL8882092 0.81 SLC6A4 (0.68) SIGMAR1SLC6A4ADRB2CYP3A4MAPK1
SCHEMBL4680337 0.80 SIGMAR1 (0.66) SIGMAR1SLC6A4CYP3A4CYP2D6TSHR
SCHEMBL31545550 0.80 SIGMAR1 (0.66) SIGMAR1SLC6A4CYP3A4SLC6A2CYP2D6
SCHEMBL22249109 0.80 SIGMAR1 (0.66) SIGMAR1SLC6A4CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275964-A1 CANNABINOID RECEPTOR LIGANDS AND USES THEREOF PFIZER, INC. 2007-11-29 US disclosed
US-7268133-B2 Cannabinoid receptor ligands and uses thereof PFIZER, INC. PATENT DEPARTMENT (US) 2007-09-11 US disclosed
US-20040214837-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC. 2004-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214837-A1 Cannabinoid receptor ligands and uses thereof CNR1, CNR2, GPR18 SIGMAR1 102/4885SLC6A4 1093/4885ADRB2 125/4885
US-20070275964-A1 CANNABINOID RECEPTOR LIGANDS AND USES THEREOF CNR1, CNR2, GPR18 SIGMAR1 133/4885SLC6A4 1066/4885ADRB2 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.